Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Basic Research in Cardiology

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00395-008-0751-yPMID 18836677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure

  2007cited by this paper
• Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure.

  2007cited by this paper
• Excitation-contraction coupling and mitochondrial energetics

  2007cited by this paper
• Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.

  2006cited by this paper
• Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator–Activated Receptor-α via Inhibition of the Protein Kinase C Signaling Pathway

  2006cited by this paper
• Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats.

  2006cited by this paper
• Enhanced acidotic myocardial Ca2+ responsiveness with training in hypertension.

  2006cited by this paper
• Reduced serine–16 and threonine–17 phospholamban phosphorylation in stunning of conscious dogs

  2006cited by this paper
• Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat

  2006cited by this paper
• Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.

  2006cited by this paper
• Reduced sarcoplasmic reticulum Ca2+-ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium

  2006cited by this paper
• Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

  2006cited by this paper
• Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.

  2005cited by this paper
• Effect of β-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats

  2005cited by this paper
• Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.

  2005cited by this paper
• Daily exercise-induced cardioprotection is associated with changes in calcium regulatory proteins in hypertensive rats.

  2005cited by this paper
• Effects of simvastatin on cardiac performance and expression of sarco-plasmic reticular calcium regulatory proteins in rat heart

  2005cited by this paper
• Noninvasive Evaluation of the Time Course of Change in Cardiac Function in Spontaneously Hypertensive Rats by Echocardiography

  2005cited by this paper
• Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

  2004cited by this paper
• Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.

  2004cited by this paper
• Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase

  2004cited by this paper
• AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure

  2004cited by this paper
• Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.

  2004cited by this paper
• ANTI‐APOPTOTIC EFFECT OF ATORVASTATIN, A 3‐HYDROXY‐3‐METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR, ON CARDIAC MYOCYTES THROUGH PROTEIN KINASE C ACTIVATION

  2004cited by this paper
• PKC-alpha regulates cardiac contractility and propensity toward heart failure.

  2004influential reference
• Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.

  2004cited by this paper
• Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes.

  2003cited by this paper
• Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy

  2003cited by this paper
• Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts.

  2003cited by this paper
• Type 1 Phosphatase, a Negative Regulator of Cardiac Function

  2002cited by this paper
• Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.

  2002cited by this paper
• Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Calcium cycling in congestive heart failure.

  2002cited by this paper
• Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase in a Rat Model of Heart Failure

  2001cited by this paper
• Patients With End-Stage Congestive Heart Failure Treated With &bgr;-Adrenergic Receptor Antagonists Have Improved Ventricular Myocyte Calcium Regulatory Protein Abundance

  2001cited by this paper
• HMG-CoA Reductase Inhibitors Prevent Migration of Human Coronary Smooth Muscle Cells Through Suppression of Increase in Oxidative Stress

  2001cited by this paper
• Enhanced protein phosphorylation in hypertensive hypertrophy.

  2001cited by this paper
• Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

  1999cited by this paper
• Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.

  1998cited by this paper
• Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.

  1995cited by this paper
• Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy

  1995cited by this paper
• Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.

  1993cited by this paper
• Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities.

  1979cited by this paper

• Differential effects of dexamethasone on arterial stiffness, myocardial remodeling and blood pressure between normotensive and spontaneously hypertensive rats

  2021cites this paper
• Cardiac‐specific deletion of FDPS induces cardiac remodeling and dysfunction by enhancing the activity of small GTP‐binding proteins

  2021cites this paper
• Dexamethasone and Training-Induced Cardiac Remodeling Improve Cardiac Function and Arterial Pressure in Spontaneously Hypertensive Rats

  2020influential citation
• Relaxant effect of atorvastatin on isolated rat gastric fundus strips: implications for Ca2+-signalling mechanisms.

  2019cites this paper
• Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I

  2017cites this paper
• Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies

  2016cites this paper
• Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?

  2016cites this paper
• Most appropriate animal models to study the efficacy of statins: a systematic review

  2014cites this paper
• Increased Na+/Ca2+ Exchanger Expression/Activity Constitutes a Point of Inflection in the Progression to Heart Failure of Hypertensive Rats

  2014cites this paper
• Abnormal amounts of intracellular calcium regulatory proteins in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome and cardiac dysfunction.

  2013cites this paper
• Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart

  2013cites this paper
• Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome

  2012cites this paper
• Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial

  2011cites this paper
• Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction

  2011cites this paper
• Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial Andrew J. LudmanDerek J. HausenloyGirish BabuJonathon Hasleton • Vinod VenugopalEdney Boston-GriffithsJohn YapDavid Lawrence • Martin HaywardShyam KolvekarGiulio Bognolo

  2011cites this paper
• WITHDRAWN: Simvastatin prevents decreased SERCA2a activity in non-ischemic heart failure in rabbits via inhibition of β-adrenergic signaling.

  2010cites this paper